{"id":"bebbcc65-bbd9-4272-b0aa-4d0c39f3df47","url":"https://pharma.lonestaroracle.xyz/catalysts?company=NVIDIA&days=365&ticker=SRPT","method":"GET","fingerprint":"f6cdc8a845907a70b7dc4709a7d1c070446da662ee855f1faa433554a72b506f","name":"PharmaCatalyst","description":null,"category":"other","docs_url":null,"advertised_price_usd":"0.050000","asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","scheme":"exact","networks":["eip155:8453","solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp"],"pay_to":"0x52Ab53912D37759B2ad364f22dD06B16714b6C06","input_schema":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"type":"object","properties":{"days":{"type":"integer","default":365,"description":"Look-ahead horizon in days (default 365, max 1095). Alias: horizon."},"ticker":{"type":"string","example":"SRPT","description":"Biotech stock ticker (e.g. SRPT, VRTX, MRNA). Resolved to a company via yfinance. Alias: symbol."},"company":{"type":"string","description":"Company name instead of a ticker (e.g. 'Vertex Pharmaceuticals'). Alias: name."}}}}},"output_schema":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"match":"sponsor","counts":{"phase2":0,"phase3":2,"next_90d":1,"total_upcoming":2},"source":"ClinicalTrials.gov API v2","ticker":"SRPT","company":"Sarepta Therapeutics, Inc.","horizon_days":365,"sponsor_query":"Sarepta","interpretation":"Near-term binary catalyst risk: a Phase 3 readout (or several trials) due within 90 days.","catalyst_signal":"HIGH","upcoming_catalysts":[{"type":"Trial Readout","phase":"Phase 3","nct_id":"NCT03992430","source":"ClinicalTrials.gov","status":"Recruiting","days_out":84,"indication":"Muscular Dystrophy, Duchenne","lead_sponsor":"Sarepta Therapeutics, Inc.","expected_readout":"2026-10-31"}]}}},"schema_completeness":0,"status":"live","first_seen_at":"2026-08-23 13:09:39.237616+00","last_seen_at":"2026-08-23 13:09:39.007+00","last_success_at":"2026-10-15 11:38:37.061+00","dead_since":null,"probe_backoff_tier":0,"next_probe_at":"2026-10-15 11:43:37.061+00","search_tsv":"'pharmacatalyst':1","catalog_number":"2414","x402_version":2,"resource_url":"https://pharma.lonestaroracle.xyz/catalysts?company=NVIDIA&days=365&ticker=SRPT","resource_description":"Upcoming biotech clinical-trial catalysts (?ticker=<biotech ticker> or ?company=)","bazaar_extension":{"info":{"input":{"type":"http","method":"GET","queryParams":{"days":365,"ticker":"SRPT","company":"NVIDIA"}},"output":{"type":"object","format":"json","example":{"match":"sponsor","counts":{"phase2":0,"phase3":2,"next_90d":1,"total_upcoming":2},"source":"ClinicalTrials.gov API v2","ticker":"SRPT","company":"Sarepta Therapeutics, Inc.","horizon_days":365,"sponsor_query":"Sarepta","interpretation":"Near-term binary catalyst risk: a Phase 3 readout (or several trials) due within 90 days.","catalyst_signal":"HIGH","upcoming_catalysts":[{"type":"Trial Readout","phase":"Phase 3","nct_id":"NCT03992430","source":"ClinicalTrials.gov","status":"Recruiting","days_out":84,"indication":"Muscular Dystrophy, Duchenne","lead_sponsor":"Sarepta Therapeutics, Inc.","expected_readout":"2026-10-31"}]}}},"schema":{"name":"PharmaCatalyst","tags":["biotech","pharma","catalyst","clinical-trials","healthcare"],"type":"object","version":"1.0.0","category":"markets","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"type":"object","properties":{"days":{"type":"integer","default":365,"description":"Look-ahead horizon in days (default 365, max 1095). Alias: horizon."},"ticker":{"type":"string","example":"SRPT","description":"Biotech stock ticker (e.g. SRPT, VRTX, MRNA). Resolved to a company via yfinance. Alias: symbol."},"company":{"type":"string","description":"Company name instead of a ticker (e.g. 'Vertex Pharmaceuticals'). Alias: name."}}}}},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"match":"sponsor","counts":{"phase2":0,"phase3":2,"next_90d":1,"total_upcoming":2},"source":"ClinicalTrials.gov API v2","ticker":"SRPT","company":"Sarepta Therapeutics, Inc.","horizon_days":365,"sponsor_query":"Sarepta","interpretation":"Near-term binary catalyst risk: a Phase 3 readout (or several trials) due within 90 days.","catalyst_signal":"HIGH","upcoming_catalysts":[{"type":"Trial Readout","phase":"Phase 3","nct_id":"NCT03992430","source":"ClinicalTrials.gov","status":"Recruiting","days_out":84,"indication":"Muscular Dystrophy, Duchenne","lead_sponsor":"Sarepta Therapeutics, Inc.","expected_readout":"2026-10-31"}]}}}},"description":"Biotech catalyst tracking made agent-callable. One x402 call takes a stock ticker (or company name) and returns a catalyst signal (HIGH / MODERATE / LOW / NONE) plus the company's upcoming late-stage clinical-trial readouts — the binary events that move biotech stocks 50-90% in a day. Each catalyst names the phase (2 or 3), the indication, the expected primary-completion date (the data-release proxy), how many days out it is, the trial status and the ClinicalTrials.gov NCT id. The biotech analog of an earnings calendar, served pay-per-call: a trading, research or risk agent asks 'what's coming for $SRPT' and gets the readout schedule. $0.05 in USDC on Base via x402. Sources: ClinicalTrials.gov API v2 (official) + yfinance for ticker resolution (all free/public). NOTE: this is the trial-readout leg — it does NOT include curated FDA PDUFA decision dates (no free feed exists for those). Companion to EquityScope, OptionsFlow, AnalystEdge and EarningsCalendar."}},"accepted_requirements":[{"raw":{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"payTo":"0x52Ab53912D37759B2ad364f22dD06B16714b6C06","amount":"50000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":300},"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","payTo":"0x52Ab53912D37759B2ad364f22dD06B16714b6C06","scheme":"exact","network":"eip155:8453","amountAtomic":"50000"},{"raw":{"asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"},"payTo":"3nmeVj5m9Uq2hSTfsVsn3tJMHRJQNMKR1AjzyUJbrSgw","amount":"50000","scheme":"exact","network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","maxTimeoutSeconds":300},"asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","payTo":"3nmeVj5m9Uq2hSTfsVsn3tJMHRJQNMKR1AjzyUJbrSgw","scheme":"exact","network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","amountAtomic":"50000"}],"bazaar_compatible":true,"bazaar_validated_at":"2026-10-15 11:38:37.061+00","bazaar_validation_error":null,"window":"24h","probes_n":10,"handshake_uptime":1,"settle_success_rate":0,"valid_result_rate":null,"latency_p50":856,"latency_p90":2055,"price_drift_pct":0,"score":0.7364,"computed_at":"2026-10-15 11:39:02.067+00","source_metadata":[{"raw":{"url":"https://pharma.lonestaroracle.xyz/catalysts?company=NVIDIA&days=365&ticker=SRPT","name":"PharmaCatalyst","method":"GET","source":"bazaar:api.cdp.coinbase.com","fingerprint":"f6cdc8a845907a70b7dc4709a7d1c070446da662ee855f1faa433554a72b506f","advertisedPriceUsd":0.05},"source_id":1,"external_id":null}],"live_endpoint_metadata":{"x402_version":2,"resource_url":"https://pharma.lonestaroracle.xyz/catalysts?company=NVIDIA&days=365&ticker=SRPT","resource_description":"Upcoming biotech clinical-trial catalysts (?ticker=<biotech ticker> or ?company=)","bazaar_extension":{"info":{"input":{"type":"http","method":"GET","queryParams":{"days":365,"ticker":"SRPT","company":"NVIDIA"}},"output":{"type":"object","format":"json","example":{"match":"sponsor","counts":{"phase2":0,"phase3":2,"next_90d":1,"total_upcoming":2},"source":"ClinicalTrials.gov API v2","ticker":"SRPT","company":"Sarepta Therapeutics, Inc.","horizon_days":365,"sponsor_query":"Sarepta","interpretation":"Near-term binary catalyst risk: a Phase 3 readout (or several trials) due within 90 days.","catalyst_signal":"HIGH","upcoming_catalysts":[{"type":"Trial Readout","phase":"Phase 3","nct_id":"NCT03992430","source":"ClinicalTrials.gov","status":"Recruiting","days_out":84,"indication":"Muscular Dystrophy, Duchenne","lead_sponsor":"Sarepta Therapeutics, Inc.","expected_readout":"2026-10-31"}]}}},"schema":{"name":"PharmaCatalyst","tags":["biotech","pharma","catalyst","clinical-trials","healthcare"],"type":"object","version":"1.0.0","category":"markets","required":["input"],"properties":{"input":{"type":"object","required":["type","method"],"properties":{"type":{"type":"string","const":"http"},"method":{"enum":["GET","HEAD","DELETE"],"type":"string"},"queryParams":{"type":"object","properties":{"days":{"type":"integer","default":365,"description":"Look-ahead horizon in days (default 365, max 1095). Alias: horizon."},"ticker":{"type":"string","example":"SRPT","description":"Biotech stock ticker (e.g. SRPT, VRTX, MRNA). Resolved to a company via yfinance. Alias: symbol."},"company":{"type":"string","description":"Company name instead of a ticker (e.g. 'Vertex Pharmaceuticals'). Alias: name."}}}}},"output":{"type":"object","required":["type"],"properties":{"type":{"type":"string"},"example":{"match":"sponsor","counts":{"phase2":0,"phase3":2,"next_90d":1,"total_upcoming":2},"source":"ClinicalTrials.gov API v2","ticker":"SRPT","company":"Sarepta Therapeutics, Inc.","horizon_days":365,"sponsor_query":"Sarepta","interpretation":"Near-term binary catalyst risk: a Phase 3 readout (or several trials) due within 90 days.","catalyst_signal":"HIGH","upcoming_catalysts":[{"type":"Trial Readout","phase":"Phase 3","nct_id":"NCT03992430","source":"ClinicalTrials.gov","status":"Recruiting","days_out":84,"indication":"Muscular Dystrophy, Duchenne","lead_sponsor":"Sarepta Therapeutics, Inc.","expected_readout":"2026-10-31"}]}}}},"description":"Biotech catalyst tracking made agent-callable. One x402 call takes a stock ticker (or company name) and returns a catalyst signal (HIGH / MODERATE / LOW / NONE) plus the company's upcoming late-stage clinical-trial readouts — the binary events that move biotech stocks 50-90% in a day. Each catalyst names the phase (2 or 3), the indication, the expected primary-completion date (the data-release proxy), how many days out it is, the trial status and the ClinicalTrials.gov NCT id. The biotech analog of an earnings calendar, served pay-per-call: a trading, research or risk agent asks 'what's coming for $SRPT' and gets the readout schedule. $0.05 in USDC on Base via x402. Sources: ClinicalTrials.gov API v2 (official) + yfinance for ticker resolution (all free/public). NOTE: this is the trial-readout leg — it does NOT include curated FDA PDUFA decision dates (no free feed exists for those). Companion to EquityScope, OptionsFlow, AnalystEdge and EarningsCalendar."}},"accepted_requirements":[{"raw":{"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","extra":{"name":"USD Coin","version":"2"},"payTo":"0x52Ab53912D37759B2ad364f22dD06B16714b6C06","amount":"50000","scheme":"exact","network":"eip155:8453","maxTimeoutSeconds":300},"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","payTo":"0x52Ab53912D37759B2ad364f22dD06B16714b6C06","scheme":"exact","network":"eip155:8453","amountAtomic":"50000"},{"raw":{"asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","extra":{"feePayer":"D6ZhtNQ5nT9ZnTHUbqXZsTx5MH2rPFiBBggX4hY1WePM"},"payTo":"3nmeVj5m9Uq2hSTfsVsn3tJMHRJQNMKR1AjzyUJbrSgw","amount":"50000","scheme":"exact","network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","maxTimeoutSeconds":300},"asset":"EPjFWdd5AufqSSqeM2qN1xzybapC8G4wEGGkZwyTDt1v","payTo":"3nmeVj5m9Uq2hSTfsVsn3tJMHRJQNMKR1AjzyUJbrSgw","scheme":"exact","network":"solana:5eykt4UsFv8P8NJdTREpY1vzqKqZKvdp","amountAtomic":"50000"}],"bazaar_compatible":true,"bazaar_validated_at":"2026-10-15 11:38:37.061+00","bazaar_validation_error":null},"sonar_metrics":{"score":0.7364,"uptime":1,"paid_success_rate":0,"valid_result_rate":null,"latency_p50":856,"latency_p90":2055,"price_drift_pct":0},"cdp_indexed":false,"confidence":"medium"}